Literature DB >> 725503

Radioimmunoassay of vasoactive intestinal polypeptide in plasma.

P G Burhol, I Lygren, H L Waldum.   

Abstract

A sensitive, precise, and specific radioimmunoassay for vasoactive intestinal polypeptide (VIP) is described, with a detection limit of 0.8 pmol/l, within assay precision of 7.8%, and between assay precision of 13.1%. The final dilution of the antiserum to bind 50% of 0.9 fmol 125I-labeled VIP was 1:250000. The antiserum showed an effective equilibrium constant (Keff) according to Scatchard of 7.4 x 1011 l/mol, an average equilibrium constant (Ko) according to Sips of 7.3 x 1011 l/mol, an index of heterogeneity (alpha) according to Sips of 0.99, and a negligible cross-reactivity with secretin. 125I-labeled VIP was prepared by a modified Chloramine-T method, and the label purified on a Sephadex G-15 column followed by a SP Sephadex C-25 column had a specific radioactivity of 1700 muCi/nmol. The present assay allows measurements of fasting plasma VIP in the very low pmol/l range and the increase and gradual fall in plasma VIP subsequent to a brief period of duodenal acidification.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 725503     DOI: 10.3109/00365527809182195

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Effects of hexamethonium and atropine on the basal levels of immunoreactive vasoactive intestinal polypeptide in dogs.

Authors:  T Misawa; Y Chijiiwa; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1986-12

2.  Gastrointestinal peptides in serum and synovial fluid from patients with inflammatory joint disease.

Authors:  I Lygren; M Ostensen; P G Burhol; G Husby
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

Review 3.  Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

Authors:  Dongmei Wu; Dongwon Lee; Yong Kiel Sung
Journal:  Respir Res       Date:  2011-04-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.